JIN, Yuxin. CRISPR-Cas9 Gene Editing: A Promising Frontier in Revolutionizing Alzheimer’s Disease Management. MedScien, [S. l.], v. 2, n. 3, p. 1052, 2024. DOI: 10.61173/mfdht347. Disponível em: https://ms.deanfrancis.press/article/view/1193. Acesso em: 4 nov. 2026.